Case Studies

Teams led by Prof. Joachim Hauber at the Heinrich Pette Institute (HPI) – Leibniz Institute for Experimental Virology and Prof. Frank Buchholz* at the…

Dr Thomas Aper, Prof. Mathias Wilhelmi and their team at the Department of Cardiothoracic, Transplant and Vascular Surgery (Director: Prof. Axel…

Poseida, Demeetra and Hera BioLabs have recently launched a new tool for the targeted alteration of genes that offers an attractive alternative to the…

For over 15 years, Prof. Thomas Blankenstein and his teams at the Max Delbrück Center for Molecular Medicine (MDC) in the Helmholtz Association and at…

Everyone has back pain at some point or other. Between 20 and 30% of Europeans have chronic back pain, and in 5% of these cases the cause is…

Around 400,000 people in Germany suffer a heart attack each year. In a fifth of those affected, this leads to a complex process of restructuring in…

In 2017 Ascenion also supported the transfer of EU-financed research projects, for example as a consortium partner on projects in the European…

The vision of introducing genes into human cells to heal life-threatening diseases is more than 50 years old. Today, the first gene therapies are…

The art of a successful breast cancer operation lies in being able to remove as much cancerous tissue as possible and avoid the formation of…

Pseudomonas aeruginosa is a much-feared hospital germ. It can cause dangerous infections, is extremely resilient, and has acquired multiple resistance…

2016 saw the market launch of a new test from Roche Diagnostics: Elecsys GDF-15. Based on research by Prof. Kai C. Wollert at the Hannover Medical…

Funding of EUR 3.5 million was secured in June 2016 by Prof. Reinhard Zeidler and his team at the Helmholtz Zentrum München. The support comes from…

With Ascenion‘s help, the MDC established a unique translational centre in 2016 - the ‚Max-Delbrück Center Cell Engineering Lab‘ (MD-CEL). Its goal is…

In September 2016 the Max Delbrück Center for Molecular Medicine (MDC) and the WILEX subsidiary Heidelberg Pharma signed an option agreement with the…

Chronic Obstructive Pulmonary Disease is characterized by the persistent narrowing of the airways, often leading to difficulties in breathing and…